Results 181 to 190 of about 28,538 (266)

Cutaneous lupus erythematosus following immunoglobulin therapy in dermatomyositis. [PDF]

J Dermatol
Alhassan E, Christianakis S, DeClerck B, Crew AB.   +3 more
europepmc   +1 more source

New‐Onset Perianal Eroded Lesion in a Pediatric Patient

Pediatric Dermatology, Volume 43, Issue 1, Page 196-198, January/February 2026.
Matthew J. Yan, Jayden Galamgam, Amy Shen, Joshua Mo, Marcia Hogeling   +4 more
wiley   +1 more source

Chronic Cutaneous Lupus Erythematosus Presenting as Acne Scars: A Case Report. [PDF]

Case Rep Dermatol
Aljuhani F, Potereau A, Chaby G.
europepmc   +1 more source

Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab. [PDF]

Acta Derm Venereol
Pogorelov D, Strotkötter H, Bjelic-Radisic V, Wesselmann U, Hübinger J, Sabulyte S, Hofmann SC, Balakirski G.   +7 more
europepmc   +1 more source

The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review [PDF]

Aleksandra Fijałkowska, Marcelina Kądziela, Agnieszka Żebrowska   +2 more
openalex   +1 more source

Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary. [PDF]

Immunotherapy
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Carroll H, Naik H, Gaudreault F, Meyers A, Musselli C, Franchimont N, Barbey C.   +17 more
europepmc   +1 more source

A Diagnostic Conundrum: Unusual Presentation of Acute Cutaneous Lupus Erythematosus Mimicking Toxic Epidermal Necrolysis. [PDF]

Eur J Rheumatol
Kamble N, Khot R, Barai S, Chaudhari S, Rathod B, Awadhiya O.   +5 more
europepmc   +1 more source

Using the revised Wilson and Cleary model to explore factors affecting quality of life (QoL) in patients with cutaneous lupus erythematosus (CLE)

, 2017
Motolani E. Ogunsanya
openalex   +2 more sources

Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study. [PDF]

Lupus Sci Med
Witte T, Fernandez-Ruiz R, Abramova N, Weinelt D, Moreau F, Klopp-Schulze L, Shaw J, Denis D, Wenzel J.   +8 more
europepmc   +1 more source

Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patients

Quitterie Murat de Montai, Clémence Masseran, Laura Perray, Alexis Mathian, Karim Dorgham, Guy Gorochov, A. Teboul, Camille Françès, Laurent Arnaud, A. Barbaud, Zahir Amoura, Caroline Charre, François Chasset   +12 more
openalex   +2 more sources